Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001731122-24-001622
Filing Date
2024-10-18
Accepted
2024-10-18 17:28:22
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A2 e5918_s-1a2.htm S-1/A 551775
2 EXHIBIT 1.1 e5918_ex1-1.htm EX-1.1 91784
3 EXHIBIT 4.7 e5918_ex4-7.htm EX-4.7 93271
4 EXHIBIT 5.1 e5918_ex5-1.htm EX-5.1 9932
5 EXHIBIT 10.40 e5918_ex10-40.htm EX-10.40 249191
6 EXHIBIT 23.1 e5918_ex23-1.htm EX-23.1 3382
7 GRAPHIC image_001.jpg GRAPHIC 6908
8 GRAPHIC image_002.jpg GRAPHIC 134965
9 GRAPHIC image_003.jpg GRAPHIC 83684
10 GRAPHIC image_004.jpg GRAPHIC 3729
11 GRAPHIC image_005.jpg GRAPHIC 5619
12 GRAPHIC image_007.jpg GRAPHIC 7320
  Complete submission text file 0001731122-24-001622.txt   1334838
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

EIN.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-281080 | Film No.: 241381537
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)